Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 104.85%32.96K | 107.97%59.55K | -3,963.69%-1.28M | -489.39%-1.47M | 86.14%-96.03K | -192.51%-679.47K | -388.89%-747.45K | -57.14%33.2K | 37.45%377.97K | -925.72%-692.68K |
| Net income from continuing operations | 324.09%2.36M | 50.72%-882.17K | 17.32%-1.01M | -751.95%-6.49M | -414.26%-2.43M | -171.90%-1.05M | -276.11%-1.79M | -32.65%-1.22M | 68.83%-762.31K | -251.38%-473.3K |
| Operating gains losses | ---- | ---- | ---- | 1,790.04%178.46K | 329.29%231.93K | -148.35%-53.47K | ---- | ---- | 91.75%9.44K | -421,375.00%-101.15K |
| Depreciation and amortization | -73.51%34.51K | ---- | -85.01%28.45K | -31.95%502.27K | ---6.2K | --130.27K | ---- | -2.91%189.83K | -20.68%738.05K | ---- |
| Asset impairment expenditure | --0 | --0 | --0 | --528.05K | --525.95K | --0 | --0 | --2.1K | --0 | --0 |
| Remuneration paid in stock | --0 | --0 | --1.19K | --168.57K | --134.82K | --15.75K | --0 | --0 | --0 | --0 |
| Other non cashItems | -879.18%-3.01M | -52.05%285.56K | 65.33%428.37K | 21.22%1.64M | 329.62%584.23K | -30.95%386.48K | 40.86%595.5K | 5.55%259.1K | 13.72%1.35M | 49.29%-254.43K |
| Change In working capital | 709.76%654.09K | 46.70%656.17K | -191.47%-732.81K | 309.73%2.01M | 244.10%867.25K | -123.80%-107.27K | 132.84%447.29K | 44.24%801.15K | -294.36%-957.64K | -34.90%-601.83K |
| -Change in receivables | -95.30%5.31K | 185.11%14.68K | -83.78%20.95K | 45.76%201.27K | -106.13%-23.68K | 452.14%112.99K | 97.29%-17.25K | -64.84%129.21K | 145.15%138.08K | 191.09%386.5K |
| -Change in inventory | --0 | --0 | --0 | 228.14%702.14K | 107.30%42.64K | -92.43%37.94K | 173.70%154.27K | 282.62%467.29K | -456.04%-547.97K | -195.01%-583.78K |
| -Change in prepaid assets | 294.17%35.41K | -439.58%-22.87K | 91.25%-10.47K | -100.66%-629 | -20.90%130.47K | -271.54%-18.24K | 117.27%6.74K | -186.97%-119.6K | 188.70%94.9K | 18,858.16%164.94K |
| -Change in payables and accrued expense | 355.61%613.38K | 118.87%664.36K | -329.24%-743.3K | 268.93%1.09M | 222.54%697.82K | 53.90%-239.96K | 897.12%303.54K | -33.21%324.25K | -185.50%-642.66K | -425.09%-569.48K |
| -Change in other current liabilities | ---- | ---- | ---- | --20K | ---- | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 104.85%32.96K | 107.97%59.55K | -3,963.69%-1.28M | -489.39%-1.47M | 86.14%-96.03K | -192.51%-679.47K | -388.89%-747.45K | -57.14%33.2K | 37.45%377.97K | -925.70%-692.68K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 1,401.70%942.07K | 5,359.65%246.2K | 1,256.63%695.86K | 84.02%-72.37K | 98.29%-4.68K | ||||
| Net PPE purchase and sale | --0 | ---- | ---- | 1,401.70%942.07K | 5,359.65%246.2K | 1,256.63%695.86K | ---- | ---- | 84.02%-72.37K | 98.29%-4.68K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 1,401.70%942.07K | 5,359.65%246.2K | 1,256.63%695.86K | --0 | --0 | 84.02%-72.37K | 98.29%-4.68K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -83.29%-18.91K | -211.53%-433.4K | 887.14%1.24M | 449.61%492.42K | 95.45%-10.65K | -111.85%-10.31K | 1,935.64%388.59K | 362.36%125.89K | -144.10%-140.85K | -268.45%-233.94K |
| Net issuance payments of debt | -65.63%-18.91K | -112.53%-48.7K | -694.43%-748.31K | 137.07%491.32K | 97.80%-10.65K | 98.65%-11.41K | 1,935.64%388.59K | 362.36%125.89K | -34.91%-1.33M | -563.40%-483.85K |
| Net common stock issuance | --0 | --200.3K | --1.41M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | -99.91%1.1K | -100.00%1 | -98.21%1.1K | ---- | ---- | -9.01%1.18M | -0.30%1.12M |
| Net other financing activities | ---- | ---585K | --585K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -83.29%-18.91K | -211.53%-433.4K | 887.14%1.24M | 449.61%492.42K | 95.45%-10.65K | -111.85%-10.31K | 1,935.64%388.59K | 362.36%125.89K | -144.10%-140.85K | -268.45%-233.94K |
| Net cash flow | ||||||||||
| Beginning cash position | -72.94%15.41K | -45.78%222.66K | -93.85%31.18K | 34.61%506.58K | -92.18%93.58K | -87.29%56.94K | -0.39%410.68K | 34.61%506.58K | 46.36%376.34K | 100.58%1.2M |
| Current changes in cash | 131.27%14.06K | -4.17%-373.85K | -125.10%-39.94K | -122.62%-37.27K | 114.98%139.53K | -99.20%6.08K | -252.07%-358.86K | 61.11%159.09K | 16.40%164.75K | -129.65%-931.3K |
| Effect of exchange rate changes | -155.11%-16.84K | 3,149.86%166.59K | 184.77%231.42K | -1,169.86%-438.14K | -183.53%-201.93K | 332.87%30.56K | 102.56%5.13K | -334.82%-272.99K | -54.56%-34.5K | 30.30%241.76K |
| End cash Position | -86.51%12.62K | -72.94%15.41K | -43.30%222.66K | -93.85%31.18K | -93.85%31.18K | -92.18%93.58K | -87.29%56.94K | -4.76%392.68K | 34.61%506.58K | 34.61%506.58K |
| Free cash from | 104.85%32.96K | 107.97%59.55K | -3,963.69%-1.28M | -581.61%-1.47M | 86.23%-96.03K | -200.77%-679.47K | -390.67%-747.45K | -53.58%33.2K | 271.84%305.59K | -103.89%-697.36K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.